OCTOPUS ROBOTS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -.--% |
| 2023 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
| 2023 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| Sales 2021 | 537K 574K 47.88M | Sales 2022 | 277K 297K 24.75M | Capitalization | 1.7M 1.81M 151M |
|---|---|---|---|---|---|
| Net income 2021 | -1M -1.07M -89.18M | Net income 2022 | - 0 0 | EV / Sales 2021 | 9 x |
| Net Debt 2021 | 1.65M 1.76M 147M | Net Debt 2022 | 2.64M 2.82M 235M | EV / Sales 2022 | 15.6 x |
| P/E ratio 2021 |
-3.16
x | P/E ratio 2022 |
-2.11
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 01/20/01 |
Élodie Giroux
COO | Chief Operating Officer | - | 01/20/01 |
Dorian Pierre
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 01/20/01 |
| Director/Board Member | 74 | 22/20/22 | |
| Director/Board Member | 49 | 29/21/29 |
Octopus Biosafety specializes in the design, manufacturing and marketing of mobile, multi skilled and autonomous decontamination robots incorporating in house artificial intelligence. These robots are equipped with a patented system for the decontamination of high-volume buildings (livestock buildings, agri-food sector, establishments receiving public services, airports, etc.).
This solution makes it possible to fight effectively against multi-resistant bacteria, pandemics and bioterrorism. Moreover, multiple on-board sensors ensure a full data traceability.
Sector
-
